gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Cleft lip and palate associated transmembrane protein 1

CLPTM1, Cleft Lip and Palate Transmembrane Protein 1
Top mentioned proteins: LIP, telomerase reverse transcriptase, OUT, SET, Mima
Papers on CLPTM1
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
Klein et al., Baltimore, United States. In Nat Genet, Aug 2015
We replicated previously reported associations at 9q34.2 (ABO), 13q22.1 (KLF5), 5p15.33 (TERT and CLPTM1), 13q12.2
Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency.
Murase et al., Tokyo, Japan. In Clin Chim Acta, 2015
The 5' part of the breakpoint was located in an Alu Sx repetitive element in intron 1 of APOC2, whereas the 3' part of the breakpoint was in another Alu Sx between APOC2 and CLPTM1, a gene flanking APOC2.
CLPTM1L polymorphism and lung cancer risk.
Zhao et al., Wuxi, China. In Int J Clin Exp Med, 2014
The association of Cleft Lip and Palate Transmembrane Protein 1 (CLPTM1L) rs31489 polymorphism with risk of lung cancer has been evaluated in many studies; however, the results from these studies are controversial.
Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
Ribas et al., Valencia, Spain. In Eur J Cancer, 2014
Telomere length has been associated with the development of cancer.
Cleft lip and palate transmembrane protein 1 rs31489 polymorphism is associated with lung cancer risk: a meta-analysis.
Li et al., Shanghai, China. In Tumour Biol, 2014
The potentially functional polymorphism, rs31489, in the promoter region of cleft lip and palate transmembrane protein 1 (CLPTM1L) gene has been implicated in cancer risk.
Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population.
Lu et al., Shanghai, China. In Exp Lung Res, 2013
Recent genome-wide association studies and consecutive validation supported that the 5p15.33 region containing telomerase reverse transcriptase gene (TERT) and cleft lip and palate transmembrane protein 1-like (CLPTM1L) gene showed significant association with lung cancer in multiple populations.
No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population.
Kong et al., Hangzhou, China. In Asian Pac J Cancer Prev, 2012
BACKGROUND: This study aimed to explore potential associations between single nucleotide polymorphisms (SNPs) of the x-ray repair cross-complementing group 1 (XRCC1) and cleft lip and palate transmembrane protein 1-like (CLPTM1L) and non-small cell lung cancer (NSCLC) susceptibility in non-smoker Chinese patients.
Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus.
You et al., Milwaukee, United States. In Plos One, 2011
Cleft Lip and Palate Transmembrane Protein 1-Like (CLPTM1L), resides in a region of chromosome 5 for which copy number gain has been found to be the most frequent genetic event in the early stages of non-small cell lung cancer (NSCLC).
Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients.
Folgueira et al., São Paulo, Brazil. In Braz J Med Biol Res, 2010
Among five trio combinations previously identified, defined by nine genes individually investigated (BZRP, CLPTM1, MTSS1, NOTCH1, NUP210, PRSS11, RPL37A, SMYD2, and XLHSRF-1), the most accurate were established by RPL37A, XLHSRF-1 based trios, with NOTCH1 or NUP210.
The association of telomere length and genetic variation in telomere biology genes.
Savage et al., Bethesda, United States. In Hum Mutat, 2010
Recent genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in genes encoding telomere-associated proteins (RTEL1 and TERT-CLPTM1) as markers of cancer risk.
Protein macroarray profiling of serum autoantibodies in pseudoexfoliation glaucoma.
Murphy et al., Dublin, Ireland. In Invest Ophthalmol Vis Sci, 2010
RESULTS: An increased prevalence was detected among the PXFG patients of serum antibodies to seven proteins: C6orf129; stathmin-like 4; transmembrane protein 9 domain family, member B; fibroblast growth factor receptor 3; cleft lip and palate transmembrane protein 1; EH-domain-containing protein 1; and eukaryotic translation elongation factor 2. All antigens were expressed in the RGC-5 cells and in cDNA from human brain and optic nerve, with the exception of stathmin-like 4, which was not expressed in the RGC-5 cells.
Human cleft lip and palate fibroblasts and normal nicotine-treated fibroblasts show altered in vitro expressions of genes related to molecular signaling pathways and extracellular matrix metabolism.
Bodo et al., Perugia, Italy. In J Cell Physiol, 2010
Interestingly, nicotine treatment regulated gene expressions of CD44 and CLPTM1, two candidate genes for CLP.
Testing reported associations of genetic risk factors for oral clefts in a large Irish study population.
Mills et al., Bethesda, United States. In Birth Defects Res A Clin Mol Teratol, 2010
We used a large, ethnically homogenous study population to test whether reported associations between nonsyndromic oral clefts and 12 genes (CLPTM1, CRISPLD2, FGFR2, GABRB3, GLI2, IRF6, PTCH1, RARA, RYK, SATB2, SUMO1, TGFA) could be confirmed.
Isolation of heat shock factor HsfA1a-binding sites in vivo revealed variations of heat shock elements in Arabidopsis thaliana.
Zhang et al., Kunming, China. In Plant Cell Physiol, 2008
Hsp21, Hsp81-1, Hsp101, and several novel genes encoding a non-race specific disease resistance protein and a transmembrane CLPTM1 family protein.
Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.
Folgueira et al., São Paulo, Brazil. In Acta Vet Scand, 2007
BACKGROUND: In women with breast cancer submitted to neoadjuvant chemotherapy based in doxorubicin, tumor expression of groups of three genes (PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2) have classified them as responsive or resistant.
Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.
Ionov et al., Buffalo, United States. In Cancer Genet Cytogenet, 2005
Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells
share on facebooktweetadd +1mail to friends